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Abstract
Several studies have been reported on the occurrence of sperm motility inhibiting factors in the male reproductive fluids of
different mammalian species, but these proteins have not been adequately purified and characterized. A novel sperm
motility inhibiting factor (MIF-II) has been purified from caprine epididymal plasma (EP) by Hydroxylapatite gel adsorption
chromatography, DEAE-Cellulose ion-exchange chromatography and chromatofocusing. The MIF-II has been purified to
apparent homogeneity and the molecular weight estimated by Sephacryl S-300 gel filtration is 160 kDa. MIF-II is a dimeric
protein, made up of two subunits each having a molecular mass of 80 kDa as shown by SDS-PAGE. The isoelectric point of
MIF-II is 5.1 as determined by chromatofocusing and isoelectric focusing. It is a heat labile protein and maximal active at the
pH 6.9 to 7.5. The sperm motility inhibiting protein factor at 2 mg/ml (12.5 nM) level showed maximal motility-inhibiting
activity. The observation that the epididymal plasma factor lowered the intracellular cAMP level of spermatozoa in a
concentration-dependent manner suggests that it may block the motility of caprine cauda spermatozoa by interfering the
cAMP dependent motility function. The results revealed that the purified protein factor has the potential of sperm motility
inhibition and may serve as a vaginal contraceptive. The antibody raised against the MIF-II has the potential for
enhancement of forward motility of cauda-spermatozoa. This antibody may thus be useful for solving some of the problems
of male infertility due to low sperm motility.
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Introduction
Reproduction is a normal process of life. Sperm maturity/
motility is essential to acquire fertilizing ability of male gamete.
When mammalian sperm first enter the epididymis from the testis
they are neither motile nor fertile. As they travel down the
epididymis, they gradually acquire full capacity for progressive
motility [1]. Once maturation is complete, spermatozoa are
maintained in a quiescent state in the cauda epididymis until
ejaculation. Several reports are there that mammalian reproduc-
tive fluids contain some factors, which cause quiescence of sperm.
The quiescence has been reported for the rat, mouse, hamster [2]
and bull spermatozoa [3]. Wong & Lee [4] suggested that rat
spermatozoa immobilized by hyperpolarization of the sperm
membrane resulting from a Na
+ influx parallel by H
+ efflux.
Studies on the bovine [5] reported clearly that its relatively low pH
of about 5.5 acts in concert with some yet unidentified quiescence
factor to maintain their immotile state. The quiescent state of rat
spermatozoa in the distal epididymis may be dependent on a
specific inhibitor protein, presumably acting at the sperm surface
[6]. Usselman & Cone [7] demonstrated a high molecular
glycoprotein, called ‘‘Immobilin’’ that immobilizes rat sperm
mechanically by increasing the viscoelastic drag of rat cauda
epididymal (CE) fluid. In our previous report we have discussed
about the occurrence of motility inhibiting factor from caprine
EP [8].
Poor sperm motility is one of the major causes of male infertility.
The seminal plasma (SP) of many mammals investigated for the
presence of motility inhibitors [9]. Rat seminal vesicle secretion
possesses both motility promoting as well as inhibitory protein
factors as resolved by gel filtration on Bio-gel P-150 [10]. Jeng et al.
[11] have purified two sperm motility inhibitors (SMI-1 and SMI-
2) form porcine seminal plasma. A sperm motility inhibitor from
boar seminal plasma was also purified [12]. Bass et al. [13] found
some non dialyzable factors in bovine seminal plasma that affect
the viability and motility of spermatozoa. Human seminal plasma
also contains a sperm motility inhibitor (SPMI) that originates
from seminal vesicles as a 52 kDa precursor form and is degraded
into smaller peptides by prostatic proteases shortly after ejacula-
tion [14,15]. Recently we have purified a 100 kDa sperm motility
inhibiting factor (MIF) from goat cauda plasma membrane [16].
Though microscopic method is the most widely used subjective
method for sperm motility analysis [17], here, other than this
method, spectrophotometric methods were also used to estimate
motility in terms of change in absorbance or optical density [18].
Another sophisticated instrument ‘‘Computer aided semen
analyzer’’ (CASA) was utlilised that is based on microscopic video
photographic method and used for estimating sperm ‘‘horizontal’’
velocity [19]. To determine ‘‘vertical’’ velocity of spermatozoa a
unique computer-based spectrophotometric system was developed
in our laboratory recently [20] and used for the purpose. This
instrument has been named as ‘‘SPERMA’’. Undertaking upward
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horizontal movement; average vertical velocity is expected to be a
much better identifying parameter for assessing quality of
spermatozoa.
The current investigation has been undertaken for the first time
to purify and characterize a potent sperm motility inhibiting factor
(MIF-II) from caprine epididymal plasma (EP). Various assay
procedures have been used to study the accurate level of the MIF-
II activity on sperm forward motility as well as its velocity.
Results
Purification of motility inhibiting factor (MIF-II) from goat
epididymal plasma
The summary of the purification of MIF-II from EP has been
shown in Table 1. When hydroxylapatite gel adsorption chro-
matography was performed, 100% MIF-II activity was adsorbed
by the gel. Activity was successfully eluted by the 0.5 M K-
phosphate buffer at pH 7.0, with 70–80% recovery (Fig. S1.A). By
this step, MIF-II was purified 18–20 folds. The active fraction
from hydroxylapatite gel adsorption was further purified by
DEAE-cellulose ion-exchange chromatography. MIF-II binds to
the resin and activity was eluted with 0.2 M K-phosphate buffer,
pH 7.5 (Fig. S1.B). MIF-II was further subjected to chromatofo-
cusing, it showed single peak at the pI value of 4.8 to 5.1
approximately (Fig. S1.C). By these steps, MIF-II activity was
purified about 770-fold.
Physical properties of MIF-II
Purity of MIF-II was checked by native polyacrylamide gel
electrophoresis. 15 mg of the purified MIF-II showed a single protein
band indicating apparent homogeneity of the factor (Fig. 1A). One
part of the gel was stained with silver nitrate and from another
portion MIF-II activity was eluted in RPS medium. MIF-II activity
co-migrated with the protein band (Fig. 1B). Molecular weight of the
purified MIF-II as estimated by Sephacryl S-300 gel filtration was
approx. 160 kDa (Fig. 2). Only one peak was found when MIF-II
activity was subjected to gel filtration on Sephacryl S-300.
To determine the subunit composition of MIF-II, the purified
MIF-II (20 mg) was subjected to SDS-PAGE. Single protein band
of 80 kDa molecular weight was observed in the gel electrophor-
etogram (Fig. 3). Apparent stoichiometric analysis indicated that
the protein was in dimeric form. The total value (80 kDa 62
=160 kDa) was also consistent with the molecular weight
obtained by the gel filtration chromatographic technique. The
result indicates that MIF-II is a homodimer of two 80 kDa
peptides. The isoelectric point of MIF-II is around 5.1 as obtained
in chromatofocusing (Fig. S1.C). Using isoelectric focusing the pI
point was further confirmed as 5.1 (Fig. 4).
Biochemical Properties of MIF-II
The motility inhibiting activity of purified MIF-II increased
linearly up to 6.5 units at the concentration of 1 mg/ml (6.25 nM).
The inhibitory effects of the factor showed maximal activity
(approx. 92%) at 2 mg/ml (12.5 nM) concentration of MIF-II
Table 1. Purification of MIF-II from caprine epididymal plasma.
Fractions Total Activity Total Protein (mg) Specific Activity Recovery (%) Fold Purification
EP 2786 279 10 100 1
Hydroxylapatite gel adsorption 2070 10.5 197 74.3 19
DEAE Ion-exchange Chromatography 1420 1.22 1163 50.96 116
Chromatofocusing 1540 0.2 7700 55.27 770
doi:10.1371/journal.pone.0012039.t001
Figure 1. Non-denaturing polyacrylamide gel electrophoresis of the purified MIF-II on 5% gel. Staining of gel and MIF-II activity elution
from gel were carried out as described in ‘‘Materials & Methods’’ section. A) 15 mg of purified MIF-II. B) MIF-II activity measured from the gel slices.
doi:10.1371/journal.pone.0012039.g001
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The factor shows linear decrease of sperm forward motility and it
completes within 5 min. MIF-II (10 mg/ml) when heated at 60uC,
80uC and 100uC for 2 min, cooled at room temperature and then
assayed for motility inhibiting activity under the standard assay
conditions, showed complete loss of activity at 100uC (Table 2).
The data shows that MIF-II is heat labile protein. To elucidate the
effects of pH upon the MIF-II activity, the motility of cauda
epididymal sperm was studied in presence and absence of MIF-II
in different pH. The motility was suppressed at the lower pH 4.0
to 4.5 in control as well as in treated sample. Observed optimum
pH of MIF-II activity was 6.9 to 7.5. In alkaline pH 7.5 onwards,
the MIF-II activity was lost (Fig. 6).
Sperm motility assay by various motility analyzers
Analysis by CASA. Application of 2 mg/ml MIF-II to the
sperm preparation caused total immobilization of all the sperm
cells. Thus, 1 mg/ml was taken as the dose to see the effect of MIF-
II on motility variables of CASA. There was approx. 45%
decrease in VAP, approx. 50% decrease in VSL, approx. 25%,
decrease in VCL (Fig. 7.A).
Analysis by SPERMA. Purified MIF-II at different concen-
trations was tested on vigorously motile goat spermatozoa. Higher
velocity cells were taken for the inhibitor assay. By applying
inhibitor (1 mg/ml; suboptimal level) the vertical velocity
decreased from around 80 mm/sec to 48 mm/sec (Fig. 7.B).
MIF-II inhibited the sperm motility completely at optimum level
(2 mg/ml), so no vertical velocity was recorded. As vertical
movement is much more difficult, therefore, vertical velocity
corresponds to the actual condition of the cells.
Effect of MIF-II on human spermatozoa
MIF-II inhibits human sperm motility in dose dependent
manner (Fig. 8.A). At 2 mg/ml MIF-II reduces forward motility by
around 95%. When analyzed by SPERMA, it showed almost
complete reduction in vertical velocity of spermatozoa at optimum
concentration (Fig. 8.B).
Intracellular cAMP concentration
MIF-II reduces intracellular cAMP level in dose dependent
manner. When cAMPi was measured upon incubation with 2 mg
Figure 2. Determination of molecular weight of MIF-II by Sephacryl S-300 gel filtration. The molecular weight of MIF-II was estimated
using a column of Sephacryl S-300 (1660 cm) by modification of the method of Wollny et al. (1981). The Mol. Wt. Markers used as standard were
thyroglobulin (669 kDa), apoferritin (443 kDa), b-amylase (200 kDa), alcohol dehydrogenase (150 kDa), BSA (66 kDa), carbonic anhydrase (29 kDa)
and cytochrome C (12.4 kDa).
doi:10.1371/journal.pone.0012039.g002
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PLoS ONE | www.plosone.org 3 August 2010 | Volume 5 | Issue 8 | e12039Figure 3. SDS-PAGE of MIF-II using 10% polyacrylamide gel. Markers used as standard were b-galactosidase (116 kDa), phosphorylase b
(97 kDa), bovine serum albumin (66 kDa), ovalbumin (45 kDa) and carbonic anhydrase (29 kDa). Purified MIF-II (20 mg) was loaded.
doi:10.1371/journal.pone.0012039.g003
Figure 4. Isoelectric focusing of purified MIF-II using sucrose density gradients technique. Purified MIF-II was subjected to sucrose
density gradient tube gel and focused according to the procedure described in ‘‘Materials & Methods’’ section.
doi:10.1371/journal.pone.0012039.g004
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6 cells, it showed around 70% decrease in intracellular
cAMP level (Fig. 9).
Western blot
As shown in Fig. 10.B only one stained band was obtained on
nitrocellulose membrane upon Western blotting of the epididymal
plasma after DEAE cellulose chromatography. The stained band
corresponds to the position of the MIF-II thereby demonstrating
the antibody has high immunological specificity only for MIF-II.
Effect of MIF-II antibody on goat cauda sperm forward
motility
MIF-II antibody at dilution 1:5000, promotes sperm motility by
75% as compared to the control pre-immune serum treated sperm
within 30 min. of incubation (Fig. 11.A). Low motile sperm
populations were taken for microscopic assay to determine the
motility promoting activity of MIF-II antibody. When analyzed by
SPERMA,itshowed40%increaseinverticalvelocityofspermatozoa
as compared tothe control serum(Fig. 11.B).The control serumfrom
non-immunized rabbit did not show any effect on sperm motility.
These results indicate the presence of MIF-II on sperm surface.
Discussion
Male reproductive fluids contain a variety of biochemical
components that are essential for sperm functions. Male infertility
accounts for the failure of conception in approximately 30% of
infertile couples [21]. One of the major causes of male infertility is
due to low/no sperm motility (asthenospermia) [22]. Previous
studies suggested that the seminal plasma of different species bull,
boar, porcine, buffalo and human contain some sperm motility
inhibitory factors [9,11,12,13,23]. Sperm motility inhibitors
(SPMI) have been purified from human [14] and boar [12]
seminal plasma. Occurrence of motility inhibiting protein factor
has been reported in epididymal plasma of bovine [5], rat [6,7]
and caprine [8]. But there are no reports on the purification and
characterization of these factors from epididymal plasma [24].
However, validity of the earliest reports on the occurrence of the
motility inhibitor in different reproductive fluids remains to be
proved in view of the observations that washed spermatozoa stick
to the glass surface of hemocytometer which is widely used for
sperm motility assays and this phenomenon of ‘‘cell- sticking’’ may
give rise to artifact in motility estimations [25]. In the present
study, sperm motility assays have been carried out in presence of
goat boiled EP that contains adequate amount of antisticking
factor that ruled out the possibility of ‘‘cell- sticking’’ artifact in
motility assays. Boiled EP is devoid of motility inhibitor as MIF-II
is a heat labile protein (Table 2) on other hand; antisticking factor
present in EP is a heat stable protein [25]. The present
investigation reports for the first time purification of sperm
motility inhibiting protein (MIF-II) from caprine epididymal
plasma and some of its physical and biochemical characterizations.
The effectiveness and accuracy was judged by various assay
procedure to prove authenticity of MIF-II.
The MIF-II was purified from caprine EP to apparent
homogeneity by hydroxylapatite gel adsorption chromatography,
DEAE-cellulose ion-exchange chromatography and chromatofo-
cusing. By using these steps, MIF-II was purified to about 770 fold
with 55% recovery (Table 1). The native molecular mass of the
purified MIF-II is approx. 160 kDa as estimated by Sephacryl S-
300 gel filtration (Fig. 2). MIF-II when subjected to denaturing
SDS polyacrylamide gel electrophoresis, resolves a single protein
band of 80 kDa (Fig. 3), thereby showing that the native MIF-II is
a homodimer possessing two subunits each having a molecular
mass of 80 kDa. The MIF-II is a heat labile (Table 2) and acidic
Figure 5. Dose course and time course of MIF-II. A) Dose course of action of purified MIF-II under the standard assay conditions. B) Time course
of the action of MIF-II under the standard assay conditions. Amount of MIF-II used was 2 mg/ml. The data shown are mean 6 SEM of three
experiments.
doi:10.1371/journal.pone.0012039.g005
Table 2. Effect of heat treatment on motility inhibiting
activity of purified MIF-II.
Heat treatment (uC) MIF-II activity (units) (Mean ± SEM)
Nil 7.360.28
60 2.860.41
80 1.660.32
100 0
doi:10.1371/journal.pone.0012039.t002
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by chromatofocusing (Fig. S1.C) and isoelectric focusing (Fig. 4).
The novel motility inhibitory protein from EP is clearly different
from that of seminal vesicle secretion. SP motility inhibitors
(SPMI) of boar and human have pI of 8.7 and 9.0, respectively
[12,14] showing that they are basic proteins in contrast to the EP
factor, which is an acidic protein. Further the EP motility inhibitor
has markedly higher molecular size (160 kDa) as compared to that
of seminal plasma inhibitor of boar (50 kDa) and human (18 kDa).
Unlike the trimeric SP factor of boar, caprine EP factor is a
dimeric protein. Biochemical basis of this marked variation of the
molecular mass of motility inhibiting factors is not clear. It may be
due to species variation or due to proteolytic breakdown of native
protein. Previously we had purified a 100 kDa motility inhibitory
factor (MIF) from caprine mature sperm plasma membrane [16].
The data demonstrate that the MIF-II is different from MIF as the
sources of isolation of both the factors are different. MIF was
isolated from the sperm plasma membrane whereas MIF-II is
isolated from epididymal plasma. MIF (from goat sperm plasma
membrane) is a heat stable, D-galactose specific glycoprotein
whereas MIF-II (from EP) is a heat labile protein factor [Table 2].
The molecular mass of plasma membrane MIF is 100 kDa, which
is markedly lower than that of epididymal plasma MIF-II
(160 kDa). Unlike the monomeric MIF, the MIF-II is a dimeric
protein. MIF-II is active at neutral pH (6.9–7.0) but it lost its
activity at alkaline pH (Fig. 6) whereas the activity of sperm plasma
membrane MIF is not pH dependent [16]. MIF-II not only
inhibits goat cauda sperm forward motility, but also vertical
velocity which is far better index of sperm quality (Fig. 7). MIF-II
also inhibits human sperm forward motility as well as vertical
velocity almost completely at a concentration of 2 mg/ml (Fig. 8).
It implicates that though its source is caprine but its activity is not
species specific. MIF-II is highly immunogenic and its antibody
raised in rabbit has high immunological specificity as indicated by
western blotting pattern (Fig. 10). Interestingly, antibody of MIF-II
significantly increases not only sperm forward motility, but also
sperm vertical velocity (Fig. 11). It is possible that the observed
motility-inhibiting activity of MIF-II may be due to non-specific
Figure 6. Effect of pH on the activity of MIF-II. Standard assay conditions were used except for the variation in pH of the RPS medium. Amount
of MIF-II used was 2 mg/ml each. The data shown are mean 6 SEM of three experiments. (¤): Control; (&): MIF-II treated (% FM); (m): MIF-II treated (%
FM inhibition).
doi:10.1371/journal.pone.0012039.g006
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PLoS ONE | www.plosone.org 6 August 2010 | Volume 5 | Issue 8 | e12039Figure 7. Assessment of MIF-II activity using CASA & SPERMA. A) Effect of MIF-II (1 mg/ml) on different CASA parameters. Data represents
mean of three experiments (n=3) 6 SEM. Units: VAP (Average Path Velocity) = mm/sec, VSL (Straight Line Velocity) = mm/sec, VCL (Curvilinear
Velocity) = mm/sec. When treated with 2 mg/ml of MIF-II velocity becomes undetectable. B) Effect of MIF-II (1 mg/ml) on vertical velocity of goat
cauda sperm measured by SPERMA. The values indicate the mean 6 SEM of three experiments. At optimum concentration (2 mg/ml) no vertical
velocity was found.
doi:10.1371/journal.pone.0012039.g007
Figure 8. Effect of different concentration of MIF-II on human sperm. A) Effect of MIF-II on forward motility of human sperm. B) Effect of MIF-
II on vertical velocity of human sperm.
doi:10.1371/journal.pone.0012039.g008
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estimate the forward motility-inhibiting activity of other available
proteins such as BSA (66 kDa), caprine IgG (150 kDa). BSA at a
concentration of 2 mg protein/ml and caprine IgG (1:500 dilution)
had no detectable effect on sperm motility (Fig. S2). However,
MIF-II at a concentration as low as 2 mg protein/ml showed
maximal activity when it inhibits forward motility almost
completely. The results support the notion that the inhibitory
action is specific for MIF-II.
Since decades, cyclic AMP (cAMP) has been reported to play an
important role in both the initiation and maintenance of sperm
motility [26].Several investigators using multiple mammalian species
have demonstrated that optimal in vitro initiation of forward motility
in the immature caput-sperm requires four exogenous parameters:
theophylline, epididymal plasma, bicarbonate, and alkaline pH [27].
Bicarbonate works by elevating the intrasperm level of cyclic AMP
[27,28] whereas theophylline enhances level of sperm cyclic AMP by
inhibiting cyclic phosphodiesterase [27]. These findings show that
elevated level of intrasperm cyclic AMP is one of the important
parameters for the induction of flagellar motility. Our result
demonstrates that the addition of MIF-II lowers the intrasperm
cyclic AMP level up to 45% approximately (Fig. 9). It gives a justified
reason for the inhibition of sperm motility due to lowering of
intrasperm cyclic AMP level caused by MIF-II. Mechanism of action
of MIF-II is still not clear. Increased cAMP is generally associated
with increased motility [27,28]; therefore the loss of sperm
progressive motility after MIF-II treatment must have been the
result of a downstream disruption in the cAMP pathway. MIF-II
might be lowering the intrasperm cyclic AMP level by increasing the
level of cyclic phosphodiesterase that reduces the sperm phosphor-
ylation mechanism or reduces the level of adenylate cyclase.
There are several reports on the co-occurrence of motility
initiators/promoters as well as motility inhibitors in male
reproductive fluids of multiple species. These factors may work
according to their level and concentration in the system. Motility
initiating protein (MIP) and MIF-II both present in the caprine
cauda epididymal plasma but MIP initiates the motility of caput
sperm (immature) at the concentration 30 mg/ml [29] whereas
MIF-II inhibits the motility of cauda sperm at the concentration
2 mg/ml in vitro (Fig. 5).
Population explosion is a major problem in all developing
countries. As MIF-II strongly inhibits forward motility of mature
sperm and its action isvery specific(Fig. S2), ithas thepotential to be
served as a contraceptive. Another global social problem of immense
dimension is human infertility [21]. One of the reasons of human
infertility is due to low order of sperm motility. As MIF-II antibody
enhances sperm motility as well as sperm vertical velocity
significantly, it has great potentiality for rectifying some of the
problemsof human infertility utilizing various Assisted Reproductive
Technologies [30]. MIF-II antibody may also have the potential for
improving cattle breeding and preservation of endangered species.
Materials and Methods
Reagents
DEAE-cellulose, polyethylene glycol (Mw 20 kDa), imidazole,
Sephacryl S-300, gel filtration marker (MW-GF-1000), SDS
marker (MW-SDS-200), phenyl methyl sulfonyl fluoride (PMSF),
pepstatin A, leupeptin, Sodium dodecyl sulphate (SDS), TEMED,
Figure 9. Effect of MIF-II on intracellular level of cAMP. cAMP
was measured according to the procedure described in ‘‘Materials &
Methods’’ section.
doi:10.1371/journal.pone.0012039.g009
Figure 10. Determination of antibody specificity by Western
blotting. A) Gel pattern of epididymal plasma (30 mg) after DEAE-
Cellulose Chromatography. B) Western blotting of epididymal plasma
after DEAE—Cellulose Chromatography.
doi:10.1371/journal.pone.0012039.g010
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20, AP conjugated goat anti-rabbit IgG, HRP conjugated goat
anti-rabbit IgG, Ficoll-400, complete and incomplete Freund’s
adjuvants, gelatine, ammonium sulphate and bovine serum
albumin were obtained from Sigma Chemical Co., St. Louis,
MO, USA. Poly-buffer exchanger (PBE-94) and poly-buffer 74
(PB-74) were obtained from Pharmacia Fine Chemicals, Uppsala,
Sweden. NBT-BCIP was obtained from MP Biomedicals, India
Pvt. Ltd. Hydroxylapatite gel was obtained from Bio-Rad Lab.
Other chemicals used were of reagents grade.
Collection of caprine epididymis
Fresh epididymides of adult goats were obtained from the local
slaughterhouses. Spermatozoa were extracted from the tissue
within 2 to 4 hrs after slaughter of the animals.
Preparation of spermatozoa and epididymal plasma
Spermatozoa were obtained from goat cauda epididymides as
previously described [25]. Highlymotile spermatozoa wereextracted
at room temperature (32uC 61) from the epididymides in a modified
Ringer’s solution (RPS medium: 119 mM NaCl, 5 mM KCl,
1.2 mM MgSO4, 10 mM glucose, 16.3 mM potassium phosphate,
50 Units/ml penicillin, pH 6.9). Numbers of spermatozoa in the
sample were estimated with a hemocytometer. Freshly extracted
sperm preparations contained 10–20610
7cells/ml. For the prepara-
tion of goat cauda-epididymal plasma (EP), freshly extracted sperm
preparation was centrifuged at 8006g for 10 min. The supernatant
was spun again at 120006g to obtain cell-free EP. The concentra-
tions of EP in the assays were expressed as its protein content.
Preparation of sperm sample for assay in CASA
The assay conditions are as same as that of forward motility
assay under phase contrast microscope. Total cell numbers were
counted under a phase contrast microscope at 4006magnification
in a hemocytometer. Spermatozoa (0.5610
6cells) were incubated
with boiled EP (0.6 mg protein) in absence or presence of specified
amount of MIF-II at room temperature (3261uC) for 1 min in a
total volume of 0.5 ml of Ca
2+ free modified Ringer phosphate
solution. Systems lacking MIF-II served as the blanks in all assays.
Preparation of sperm sample for vertical velocity assay by
SPERMA
Extracted sperm cell numbers were counted microscopically
and the concentration was made to be around 200610
6cells/ml
with modified Ringer’s phosphate buffer solution free of Ca
2+.
400 ml of this sperm suspension and 100 ml of 10% Ficoll-400 was
mixed together so that the total assay volume became 500 ml with
a Ficoll-400 concentration of 2% following a procedure standar-
dized in our laboratory. 2% Ficoll has no adverse effect on sperm
motility and it was done so that only the motile cells swims up and
not the dead cells [20]. This makes the final solution for
application in the cuvette.
Analysis of sperm motility inhibiting activity by
microscope
MIF-II activity of EP was estimated separately by evaluating
forward motility (FM) of spermatozoa using hemocytometer as the
counting chamber. To eliminate the possibility of artifact due to
sperm adhesion to glass, motility assays were carried out in presence
of boiled EP (1.2 mg protein/ml) that contained adequate anti-
sticking activity to cause nearly 100% inhibition of sperm adhesion
to glass [25]. Spermatozoa (1610
6 cells) were incubated with boiled
EP (0.6 mg protein) in the absence or presence of specified amounts
of test samples (goat EP) at room temperature (32uC 61) for 5 min
in a total volume of 0.5 ml of RPS medium. A portion of the cell
suspension was then placed in the hemocytometer and the forward
Figure 11. Effect of MIF-II antibody (1:5000) on goat cauda sperm forward motility. A) Microscopic analysis: Blank (untreated) (¤), Control
with pre immune sera (%), MIF-II Ab (m). B) Analysis by SPERMA.
doi:10.1371/journal.pone.0012039.g011
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phase contrast microscope at 4006magnification. The percentage
of FM sperm was then calculated. A unit of activity of the MIF-II
was defined as the amount of the factor,which inhibited FM in 10%
of the cells under the standard assay conditions. The calculated
percentages of FM cells are given as the mean 6 SEM of at least
three experiments.
Analysis of sperm motility inhibiting activity by CASA
After preparation of sperm sample, analysis was performed using
the CASA system (Version: 10, HTM-IVOS CASA System,
Hamilton Thorne Research, Inc., Beverly, MA, USA.) for assessing
the activity of MIF-II. Briefly, a 5 ml aliquot of prepared sperm
samplewasplacedona Macklerchamber. Atleast200 spermatozoa
were counted with CASA to evaluate the sperm motility variables
including VAP (Average Path Velocity), VSL (Straight Line
Velocity) and VCL (Curvilinear Velocity). The CASA settings were
followed according to the manufacturer’s instruction.
Assay procedure for determination of sperm vertical
velocity by SPERMA
A unique computer-basedspectrophotometric system(SPERMA)
wasdevelopedinourlaboratoryto determine the average ‘‘vertical’’
velocity of motile cells [20]. At the beginning, the initial conditions
of the spectrophotometer were adjusted. The wavelength of the
spectrophotometer was set at 545 nm (produces highest peak for
sperm sample). The total scan time was given within a range of
about 3 to 20 minutes to obtain a saturation curve for Absorbance
Vs Time. The time interval between the start of each set of scan was
set at 1 minute (60 seconds) so that every individual scan for
different heights (1st, 2nd, 3rd or 4th) in subsequent cycles started
exactly at an interval of 60 seconds. There was no delay in time as
the movements are all well synchronized. 0.9 sec. is required to
move the cuvette from one height to the adjacent one and the entire
up and down movement to complete one cycle of scanning takes
about 6 seconds but it does not cause any interference in the
scanning intervals. The cuvette was then filled with 1.5 ml of
modified RPS and placed in the cuvette holder of the spectro-
photometer. This was important because the light beam in normal
conditionmustpassthroughthe uppermostpartofthe solution.The
computer interfacing software was initiated at this stage when the
spectrophotometer recorded the reference data and paused for
adding sperm sample. 50 ml of prepared sample was layered slowly
at the bottom of the cuvette with the help of a Hamilton Syringe.
The experimental data, Absorbance vs. Time, was acquired at four
different heights of the cuvette during each cycle of time scanning
and recorded by the help of associated computer.
Human sperm motility assay
Fresh ejaculated semen was collected from normal human
volunteers. It was allowed to liquefy for 1 hr and then centrifuged
at 5006g for 5 minutes to precipitate the sperm cells. Then the
sperm pellete was washed twice in modified Ringer’s solution free
of Ca
2+ and ultimately diluted to the required concentration.
The microscopic and spectrophotometric assay methods were
similar to that of goat sperm assay already been described.
Microscopic assays were done in Makler Chamber and assay
volumes were modified according to the availability of sperm.
Purification of sperm motility inhibiting factor (MIF-II)
Dialysed epididymal plasma was subjected to hydroxyl-apatite
gel adsorption chromatographic column (2.561.5 cm) pre-equili-
brated with 10 mM K-phosphate buffer, pH 7.0. After passing the
sample, column was washed with 10 mM K-phosphate buffer,
pH 7.0, and eluted successively with 0.1 M, 0.25 M, 0.5 M and
finally with 1 M K-phosphate, pH 7.0. Active fraction was
concentrated with polyethylene glycol and then dialyzed exten-
sively against 10 mM K-phosphate buffer, pH 7.5, for the next
step.
The resulting dialyzed MIF-II fraction was subjected to ion
exchange chromatography column of DEAE-cellulose previously
equilibrated with 10 mM potassium phosphate buffer, pH 7.5.
After passage of the sample, the column was extensively washed
with 10 mM K-phosphate buffer, pH 7.5 and eluted with 0.1 M,
0.2 M, 0.5 M and finally with 1 M K-phosphate, pH 7.5. The
active fraction was concentrated and dialyzed against start buffer
0.025 M imidazol, pH 7.4 and subjected to chromatofocusing
coloumn (0.7610 cm or 3 ml) using PBE-94, previously equili-
brated with 0.025 M imidazol, pH 7.4. Activity was eluted by
polybuffer 74-HCl, pH 4 [31]. The elution was monitored by
measuring pH of each fraction as well as activity of MIF-II. Active
fractions were pooled and concentrated and dialyzed against RPS
medium and kept at 220uC with protease inhibitors.
Polyacrylamide gel electrophoresis (PAGE) under
non-denaturing conditions
To check the homogeneity, the isolated MIF-II obtained from
the final step was analysed by PAGE under non-denaturing
conditions [32]. MIF-II 15 mg and 30 mg were subjected to
different lane of 5% polyacrylamide gel electrophoresis without
SDS. The electrophoresis was carried out towards cathode to
anode using bromophenol blue as the tracking dye at 6uC with a
constant current of 20 mA/gel. After completion of electrophor-
esis, one lane of the gel was sliced for the assay of MIF-II activity.
For elution of the MIF-II activity, each gel slice (0.5 cm thickness)
was crushed and dispersed in 0.2 ml of 10 mM potassium
phosphate buffer, pH 7.0, overnight at 6uC and the elutes were
assayed for MIF-II activity. Remaining portion of the gel was
stained with silver nitrate [33] for the detection of the protein
band.
Determination of molecular weight
The native molecular weight of MIF-II was estimated by using a
column of Sephacryl S-300 (1660 cm) by modification of the
method of Wollny et al. [34]. The gel was equilibrated with K-
phosphate buffer, pH 7.0, containing 5% glycerol. Purified and
concentrated MIF-II was loaded on the column. Each 1 ml fractions
were collected and MIF-II activity was monitored by motility assay.
The column was calibrated with known molecular weight marker,
such as cytochrome C (12.4 kDa), carbonic anhydrase (29 kDa),
bovine serum albumin (66 kDa), alcohol dehydrogenase (150 kDa),
b-amylase (200 kDa), apoferritin (443 kDa) and thyroglobulin
(669 kDa) of MW-GF-1000 kit. Calibration curve was obtained by
plotting the logarithm of known molecular weights of protein versus
their respective Ve/V0 value (Ve is the elution volume of the protein
and V0 i st h ev o i dv o l u m eo fc o l u m n ) .
Subunit composition
To determine the subunit composition of isolated MIF-II, the
factor was subjected to SDS-PAGE according to Laemmli et al.
[32]. Markers used for determination of molecular weight of the
MIF-II subunits were b-galactosidase (116 kDa), phosphorylase b
(97 kDa), albumin bovine (66 kDa), ovalbumin (45 kDa) and
carbonic anhydrase (29 kDa). 20 mg purified MIF-II was loaded.
After completion of electrophoresis, the protein bands were
detected by silver staining [33].
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To determine isoelectric point of the purified MIF-II, isoelectric
focusing in gel tube (0.6611 cm) was carried out using a
discontinuous sucrose density gradient containing 2% ampholine,
pH 4.0–6.0. A 10% polyacrylamide gel base (0.660.5 cm)
containing 2% ampholine was prepared at the bottom of the gel
tubes to support the sucrose gradient. Isolated MIF-II activity was
added with 20% and 15% sucrose. Sucrose gradient was formed
by layering successively 1 ml each of 22%, 15% and 10% sucrose
on top of the polyacrylamide gel base. Approx. 100 mg protein was
loaded. Isoelectric focusing was carried out for 4 hrs at 200 V and
2 hrs at 400 V at 6uC, using 0.1N NaOH and 0.1M acetic acid as
the cathode and anode buffers, respectively. After completion of
run, the gel base was punctured and fractions of 2 drops each were
collected. An aliquot of the fraction was assayed for MIF-II activity
and the rest was diluted ten times with distilled water and pH of
each fraction was measured by a microelectrode pH meter.
Isoelectric point of MIF-II was further estimated by chroma-
tofocusing using PBE-94 [31]. After passage of the sample, the
activity was eluted with elution buffer, polybuffer 74-HCl, pH 4.0.
An aliquot of each fraction was assayed for activity and the rest
was monitored for pH gradient using microelectrode pH meter.
Determination of intracellular cAMP
Cyclic AMP level of spermatozoa were determined using
‘‘cAMP Enzyme Immunoassay Kit, Direct’’ obtained from
Sigma-aldrich (cat. No.: CA200). The EIA Direct cyclic AMP
kit is a competitive immunoassay for the quantitative determina-
tion of cyclic AMP in samples treated with 0.1 M HCl. Samples
(i.e. spermatozoa (50610
6cells/ml) after treatment with HCl were
acetylated as acetylation of the samples increases the sensitivity of
the assay. The kit uses a polyclonal antibody to bind cAMP in a
competitive manner. Samples, alkaline phosphatase conjugate,
and antibody were simultaneously incubated at room temperature
in a secondary antibody coated multiwell plate. The excess
reagents were then washed away and substrate p-Nitrophenyl
Phosphate was added. After a short incubation time the enzyme
reaction was stopped and absorbance was recorded at 405 nm.
The intensity of the yellow color was inversely proportional to the
concentration of cAMP in either the standards or the samples. The
measured optical density was used to calculate the concentration
of cAMP [35].
Raising the polyclonal antibody against the purified
MIF-II
Antiserum against the purified MIF-II was raised in rabbit by
four successive injections. Immunization schedule comprised of
four injections at 1
st,7
th,1 5
th and 21
st day. First injection was
given subcutaneously using 500 mg of protein in complete Freund’s
adjuvant. Second and third injections were comprised of 200 mgo f
protein each with incomplete Freund’s adjuvant. Fourth injection
contained 400 mg of MIF-II with incomplete Freund’s adjuvant.
Blood was collected from the ear vein on 27
th day of inoculation
and serum was prepared and stored at 270uC. MIF-II Antibody
titre was checked by Enzyme Linked Immunosorbant Assay
(ELISA). Non-immune blood serum was collected from the same
animal before starting inoculation program.
The immunoglobulin of the immune serum was precipitated
twice with 50% ammonium sulfate. The final precipitate was
dissolved in 0.01 M PBS, pH 7.0, and excess ammonium sulfate
was removed by dialysis against the same buffer. The immuno-
globulin fraction obtained after the salt fractionation was subjected
to DEAE-cellulose chromatography. Unbound protein peak
containing IgG was eluted with 0.01 M phosphate buffer at
pH 7.0. This purified MIF-II antibody was kept in 270uC for
further immunological studies.
Enzyme Linked Immunosorbant Assay (ELISA)
50 ml of PBS (10 mM sodium phosphate pH 7.5 containing
0.9% NaCl) was added for blank and fixed amount of MIF-II was
added to microtitre plate. After washing with PBS, the wells were
blocked with PBS containing 3% BSA and incubated at 37uC for
1 hr. Then the 1
st antibody (MIF-II antibody) in PBS containing
1% BSA was added in different dilutions. Incubation and washing
was done as before followed by the addition of HRP-conjugated
goat anti rabbit IgG (2
nd antibody at a dilution of 1:1000 in PBS
containing 1% BSA). Then the plate was incubated at 37uC for
1 hr. Finally colour development was done by using 3 mM
orthophenyldiamine (OPD) in 24 mM citric acid-50 mM di-
sodium hydrogen phosphate containing 0.04% H2O2 (pH 5.1–5.4)
in PBS. Development of colour was stopped after 30 minutes with
4(N) H2SO4 and absorbance was measured at 492 nm by ELISA
reader [36].
Western blotting
For determination of immunospecificity, MIF-II antibody was
evaluated by Western blot procedure. Partially purified MIF-II
(60 mg) fraction after DEAE cellulose ion exchange chromato-
graphy was run on SDS-PAGE and transferred to nitrocellulose
membrane by Bio-Rad transblot apparatus. The immunoblot was
carried out according to the procedure of Towbin et al. [37] Non-
specific binding sites were blocked with 3% skimmed milk in TBS
(10 mM Tris-HCl, pH 7.5, containing 0.9% NaCl) for 1 h at
37uC. The nitrocellulose paper was then incubated with 1
st
antibody (MIF-II antibody); diluted at 1:2500 in TBS containing
1% BSA, overnight at 4uC. Then the blot was washed with TBS
containing 0.01% Tween-20 and after that with only TBS. After
washing the blot was incubated in alkaline phosphatase-conju-
gated goat antirabbit IgG (2nd antibody in TBS-1% BSA at
1:1000 dilution) for 1 hr at room temperature (3261uC). After
further washing, immunoreactive band was visualized using NBT-
BCIP as a chromogenic substrate for alkaline phosphatase.
Protein Estimation
Microgram quantities of protein were measured by rapid and
sensitive method developed by Bradford, 1976 [38].
Statistical analysis
All experiments were repeated at least five times. The data were
presented as the mean 6 SEM. Significance of difference between
treated and control groups were analyzed by paired Student’s t-test.
Supporting Information
Figure S1 Purification of MIF-II by using different chromato-
graphic methods. A) Hydroxylapatite gel adsorption. Epididymal
plasma MIF-II activity was subjected to hydroxylapatite gel
adsorption column. The MIF-II activity was eluted with 0.5 M
K-phosphate buffer (pH 7.0). B) DEAE-cellulose ion exchange
chromatography. Active MIF-II fraction eluted from first step was
subjected to DEAE-cellulose ion exchange chromatography. MIF-
II activity was eluted with 0.2 M K-phosphate buffer at the pH 7.5.
C) Chromatofocusing of MIF-II on PBE-94 (0.7610 cm) chroma-
tography column as described in ‘‘Materials & Methods’’ section.
Found at: doi:10.1371/journal.pone.0012039.s001 (2.30 MB
TIF)
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(66 kDa), caprine IgG (150 kDa) and MIF-II (160 kDa), only
MIF-II showed forward motility inhibition of spermatozoa.
Found at: doi:10.1371/journal.pone.0012039.s002 (0.17 MB TIF)
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